4-Desoxymescaline, or 4-methyl-3,5-dimethoxyphenethylamine, is a mescaline analogue related to other psychedelic phenethylamines. It is commonly referred to as DESOXY. DESOXY was discovered by Alexander Shulgin and published in his book PiHKAL.
§Effects
The effects of DESOXY vary significantly from mescaline, despite their chemical similarity. Users report an elevated mood and some hallucinations, although nothing as intense as visuals reported on mescaline. There has been some suggestion that the dosage level of 40â€"120 mg might be too small to achieve mescaline-like effects, but since this compound has undergone only limited human experiments it may be unsafe to increase the dosage.
§Dosage
A typical dosage is within the range of 40â€"120 mg and lasts 6â€"8 hours.
§Legality
In 1970 the Controlled Substances Act placed mescaline into Schedule I in the United States. It is similarly controlled in other nations. Depending on whether or not it is intended for human consumption, 4-desoxymescaline could be considered an analogue of mescaline, under the Federal Analogue Act and similar bills in other countries, making it illegal to manufacture, buy, possess, or distribute without a DEA or related license.
DESOXY is also an isomer of 2C-D which would cause it to fall within the definitions outlined by the Federal Analogue Act
§References
- Alexander Shulgin, Jacob, P. Structure-Activity Relationships of the Classic Hallucinogens and Their Analogs. NIDA Research Monograph 146 (Hallucinogens: An Update), 1994.
§External links
- Erowid mescaline vault
- DESOXY entry in PiHKAL
- DESOXY entry in PiHKAL • info